Scandal-ridden bio firm Sillajen to resume trading after 2.5-yr suspension
SEOUL, South Korea’s bourse operator on Wednesday decided to allow scandal-ridden bio firm Sillajen Inc. to resume its stock trading after a 2 1/2-year suspension. Trading of shares in Sillajen…